Condition
ALS (Amyotrophic Lateral Sclerosis) clinical trials and research
As of November 12, 2026, Find a Trial lists 24 ALS (Amyotrophic Lateral Sclerosis) clinical trials that are recruiting, at sites in 16 countries (most in United States (9), Italy (2), Thailand (2)). 1 was first registered in the last 30 days. By phase: Phase 1 (2), Phase 2 (2), Phase 2/3 (1). The most active sponsors are Chulalongkorn University (2), Nova Southeastern University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 24Clinical trials
- 1New in 30 days
- 16Countries
Newest ALS (Amyotrophic Lateral Sclerosis) clinical trials
All recruiting trials (24)
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Imaging markers for bulbar involvement in inclusion body myositis among IBM and comparison groups
This study tests whether ultrasound and MRI can detect swallowing and bulbar muscle problems in people with inclusion body myositis.
-
7T MRI Pilot to Find Imaging Biomarkers in ALS and related motor neuron diseases
A 7T MRI study is being done to see if ultra-high-field brain scans can reveal non-invasive biomarkers in adults with motor neuron disease, including ALS.
-
Biomarker Repository for Age-Related and Inherited Neurodegenerative Diseases
This study collects blood and genetic samples from people with neurodegenerative diseases and their families to build a shared resource for studying disease risk and biology.
-
Ultra-high-resolution PET imaging of aging, neurodegeneration, and psychotic disorders
We will test whether ultra-high-resolution PET and 3T MRI scans can reveal early brain and spinal cord changes in healthy adults and people with Alzheimer's, Parkinson's disease, ALS, PSP, REM sleep behavior disorder, or psychotic disorders.
-
Use of invasive home ventilation in Denmark
This project will see how often people with neuromuscular diseases or spinal cord injuries in Denmark used invasive home mechanical ventilation between 2016 and 2025 and what their one-year outcomes were.
-
Measuring how assistive technologies and brain-computer interfaces help people use digital devices
This project will test a Digital Assessment Interface to see if it can measure how well different assistive technologies and brain-computer interfaces help adults with spinal cord injury or ALS use computers, phones, and other digital systems.
-
CTx1000 gene therapy delivered into the cisterna magna for people with ALS
This trial will test a single-dose gene therapy called CTx1000 given into the cisterna magna to see if it is safe and tolerable for people with early ALS.
-
Tongue-strengthening exercises for people with ALS
This program will test whether daily tongue-strengthening exercises can help people with ALS maintain or improve speech and swallowing.
-
Tongue-strengthening exercises for people with ALS
This program will test whether daily tongue-strengthening exercises can help people with ALS maintain or improve speech and swallowing.
-
Tofersen for adults with ALS who do not have SOD1 mutations
This study will test whether tofersen given by lumbar puncture over 24 weeks lowers neurofilament light chain and is safe for adults with ALS who do not have SOD1 mutations.
-
Omics-based profiling to find disease mechanisms and biomarkers in Alzheimer’s, Parkinson’s, FTD, and related dementias
This project will use advanced omics tests (genetics, gene expression, proteins, and metabolites) to try to find biological markers and disease mechanisms in people with Alzheimer’s, Parkinson’s, frontotemporal and young-onset dementias, or mild cognitive impairment.
-
Thailand ALS Patient Registry
This registry will collect detailed clinical, genetic, and outcome information from adults with ALS across Thailand to track disease progression and treatment results.
-
LY4256984 for people with sporadic ALS.
This trial will test LY4256984 given into the spine to see how safe it is and how it behaves in the body for people with sporadic ALS.
-
CB03-154: testing different doses for adults with ALS
This trial tests whether CB03-154 can help adults with ALS by delaying progression and improving function compared with a placebo.
-
Personalized rTMS plus mixed-reality exercise for people with motor neuron disease
This trial tests whether combining personalized rTMS with mixed-reality exercise games can slow disease progression and improve daily function in adults with mild-to-moderate motor neuron disease.
-
At-home cortico-spinal tDCS for ALS.
This treatment tests whether daily at-home cortico-spinal tDCS can slow nerve damage and symptoms in adults with early ALS.
-
Observational study on amyotrophic lateral sclerosis
This study is collecting health information from people with ALS, those with related genetic mutations, and healthy volunteers to help improve treatments and understand the disease better.
-
Using augmented reality to improve communication for late stage ALS patients
This study is testing a new augmented reality device to see if it can help people with late stage ALS communicate better and more easily.
-
Psilocybin therapy for depression and existential distress in people with COPD, ALS, MS, or atypical Parkinson disease
This trial will test whether psilocybin therapy can reduce depression and psychological distress in adults with COPD, ALS, MS, or atypical Parkinson disease who have at least six months expected life.
-
Non-invasive treatment for ALS using MyoRegulator® device
This study is testing whether the MyoRegulator® device can safely help people with ALS improve their movement and slow down the progression of the disease.
-
Impact of Probiotics on Patients with ALS and Frontotemporal Dementia
This study is testing if a probiotic supplement can help people with ALS and frontotemporal dementia feel better and improve their health compared to those who get a placebo.
-
Identifying biomarkers for early diagnosis of motor neuron diseases
This study is trying to find new ways to diagnose motor neuron diseases early by looking at brain and muscle signals in patients to help improve their care.
-
A study on early diagnosis and biomarkers for dementia and related diseases
This study is testing new ways to spot dementia and related diseases early by looking for specific markers in the brain and body, to help people at high risk and track how well new treatments are working.
Related topics
Quick answers
How many ALS (Amyotrophic Lateral Sclerosis) clinical trials are recruiting right now?
24, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in United States (9 trials), Italy (2 trials), Thailand (2 trials), Germany (2 trials), Belgium (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.